نتایج جستجو برای: serum hbv dna

تعداد نتایج: 805947  

2013
Chien-Wei Su Yu-Wei Chiou Yi-Hsuan Tsai Ruei-Dun Teng Gar-Yang Chau Hao-Jan Lei Hung-Hsu Hung Teh-Ia Huo Jaw-Ching Wu

BACKGROUND Whether or not hepatitis B virus (HBV) genotypes, mutations, and viral loads determine outcomes for patients with HBV-induced hepatocellular carcinoma (HCC) remains controversial. AIMS To study the influence of HBV viral factors on prognoses for patients with HBV-induced HCC after resection surgery and investigate if antiviral therapy could counteract the adverse effects of viral f...

2015
Xiaosong Li Junke Zhu Guoqi Lai Lei Yan Jieli Hu Juan Chen Ni Tang Ailong Huang

Studies on molecular mechanisms of the persist infection of hepatitis B virus have been hampered by a lack of a robust animal model. We successfully established a simple, versatile, and reproducible HBV persist infection model in vitro and in vivo with the circularized HBV DNA. The cells and mice were transfected or injected with circularized HBV DNA and pAAV/HBV1.2, respectively. At the indica...

Journal: :Indian Journal of Community Health 2022

Abstract: Viral hepatitis (Hepatitis B Virus (HBV) & Hepatitis C (HCV)) related liver disease is a leading cause of morbidity and mortality especially in the patients with advanced renal failure who are treated dialysis, this due to high number blood transfusion sessions and/or cross contamination from dialysis circuits. Aims Objectives: This study aimed determine prevalence HBV HCV infecti...

Journal: :Journal of virology 2002
Ayman M Abdelhamed Colleen M Kelley Thomas G Miller Phillip A Furman Harriet C Isom

Treatment of patients with lamivudine (3TC) results in loss of detectable levels of hepatitis B virus (HBV) DNA from serum; however, the relapse rate, with regard to both reappearance of virus in the bloodstream and hepatic inflammation, is high when therapy is terminated. Although the rebound observed in patients has also been seen in animal hepadnavirus models, rebound has not been analyzed i...

ژورنال: Medical Laboratory Journal 2017
Kardi, Mohammad Taghi , Komijani, Majid, Shahin, Khashayar, Yazdi, Mahsa,

ABSTRACT           Three major hepatitis B virus (HBV) antigens include HBcAg, HBeAg and HBsAg. HBeAg is the extracellular form of HBcAg, and is seen almost exclusively in people who have circulating serum HBV DNA. Presence of HBsAg in serum indicates that the individual has contracted HBV infection. Chronic hepatitis HBeAg-negative/anti-HBe–p...

2012
E Gholami Parizad A Khosravi E Gholami Parizad K Sayehmiri R Ranjbar

Dear Editor, Chronic carriers of hepatitis infection are living throughout the world mostly in the South East of Asia. Recent studies have shown that some HBsAg negative individuals may develop some sort of chronic hepatitis B which is detectable employing some new laboratory diagnosis techniques such as molecular tests. In human during decades, HBV had many mutations by which this virus has be...

2016
Hao Li Chunyu Sheng Hongbo Liu Guangze Liu Xinying Du Juan Du Linsheng Zhan Peng Li Chaojie Yang Lihua Qi Jian Wang Xiaoxia Yang Leili Jia Jing Xie Ligui Wang Rongzhang Hao Dongping Xu Yigang Tong Yusen Zhou Jianjun Zhou Yansong Sun Qiao Li Shaofu Qiu Hongbin Song

Chronic hepatitis B infection remains incurable because HBV cccDNA can persist indefinitely in patients recovering from acute HBV infection. Given the incidence of HBV infection and the shortcomings of current therapeutic options, a novel antiviral strategy is urgently needed. To inactivate HBV replication and destroy the HBV genome, we employed genome editing tool CRISPR/Cas9. Specifically, we...

Journal: :Journal of clinical pathology 2004
C-Y Dai M-L Yu S-C Chen Z-Y Lin M-Y Hsieh L-Y Wang J-F Tsai W-L Chuang W-Y Chang

AIMS To evaluate the performance characteristics and clinical usefulness of the COBAS Amplicor HBV monitor (COBAS-AM) test in Taiwan and to examine its correlation with the Quantiplex branched DNA signal amplification (bDNA) assay for measuring serum hepatitis B virus (HBV) DNA concentrations. METHODS HBV DNA was measured by the COBAS-AM test in 149 sera from chronic HBV infected patients tha...

Journal: :jundishapur journal of microbiology 0
seyed jalal hashemi health research institute, infectious and tropical diseases research center, ahvaz jundishapur university of medical sciences, ahvaz, ir iran; health research institute, infectious and tropical diseases research center, ahvaz jundishapur university of medical sciences, ahvaz, ir iran. tel: +98-9161110261 eskandar hajiani research institute for infectious disease of digestive system, ahvaz jundishapur university of medical sciences, ahvaz, ir iran abdolrahim masjedizadeh research institute for infectious disease of digestive system, ahvaz jundishapur university of medical sciences, ahvaz, ir iran manoochehr makvandi health research institute, infectious and tropical diseases research center, ahvaz jundishapur university of medical sciences, ahvaz, ir iran ali akbar shayesteh research institute for infectious disease of digestive system, ahvaz jundishapur university of medical sciences, ahvaz, ir iran seyed pejman alavinejad research institute for infectious disease of digestive system, ahvaz jundishapur university of medical sciences, ahvaz, ir iran

background chronic hepatitis b virus (hbv) infection has a broad spectrum of manifestation, ranging from silent carrier state to advanced cirrhosis and hepatocellular carcinoma. the persistence of hbv dna in serum and hepatocytes of the cirrhotic patient could be detected by molecular techniques in spite of negative hbv serologic markers. conclusions the prevalence of obi was relatively high in...

Journal: :World journal of gastroenterology 2006
Norihiro Furusyo Hiroaki Takeoka Kazuhiro Toyoda Masayuki Murata Yuichi Tanabe Eiji Kajiwara Junya Shimono Akihide Masumoto Toshihiro Maruyama Hideyuki Nomura Makoto Nakamuta Kazuhiro Takahashi Shinji Shimoda Koichi Azuma Hironori Sakai Jun Hayashi

AIM To determine the efficacy of long-term lamivudine treatment of a large number of Japanese patients with chronic hepatitis B. METHODS In this retrospective, multi-center trial, 318 Japanese patients with chronic hepatitis B received 100 mg of lamivudine daily for up to 36 (median 21) mo. Virological response was a decline to a serum HBV DNA level less than 3.7 log copies/mL. Virological br...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید